Clinical Trials Directory

Trials / Completed

CompletedNCT03151213

Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver

Effect of Preoperative Administration of Oral Pregabalin on the Postoperative Analgesia in Patients Scheduled for Radiofrequency Ablationof Focal Lesions in the Liver

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Sherief Abd-Elsalam · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study aimed to investigate the preemptive analgesia efficacy of of preemptive pregabalin for the postoperative pain management after radiofrequency ablation (RFA) of liver cancer.

Detailed description

Our data will investigate if preemptive administration of pregabalin will have a role in reducing postoperative pain after radiofrequency ablation (RFA) of liver cancer.

Conditions

Interventions

TypeNameDescription
DRUGPregabalin 150mgPregabalin 150mg before RFA of liver cancer
OTHERPlaceboPlacebo before RFA of liver cancer

Timeline

Start date
2017-01-01
Primary completion
2017-06-01
Completion
2017-06-30
First posted
2017-05-12
Last updated
2026-03-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03151213. Inclusion in this directory is not an endorsement.

Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver (NCT03151213) · Clinical Trials Directory